Silencing EPHB2 diminished the malignant biological properties of esophagus cancer cells by blocking autophagy and Wnt/β‐catenin pathway
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Shusheng Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive System, The First Affiliated Hospital of Jinzhou Medical University, 2 Section 5, Renmin Street, Guta District, Jinzhou City,…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Receptor, EphB2, Autophagy, Wnt Signaling Pathway. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Eph receptor B2 (EPHB2) is overexpressed in some tumors and relevant to unfavorable outcomes of tumor patients. By searching Gene Expression Profiling Interactive Analysis and KM Plot websites, we discovered that EPHB2 was highly expressed in patients with esophageal cancer, leading to poor prognosis. However, the role and molecular mechanism of EPHB2 in esophagus cancer is unknown. Our study aims to unveil the underlying mechanism by which EPHB2 modulates the biological properties of esophagus cancer cells. After si‐EPHB2 transfection, the malignant biological properties of esophagus cancer cells were determined by several biological experiments. IWP‐4 was applied to block Wnt/β‐catenin signaling pathway. The expressions of autophagy and Wnt/β‐catenin signaling pathway relevant molecules were tested by western blot assay. An increased expression of EPHB2 was happened in esophagus cancer samples and loss of EPHB2 diminished esophagus cancer cells proliferation, migration, and invasion. Moreover, our data showed that depletion of EPHB2 blocked the autophagy and in‐activated Wnt/β‐catenin signaling pathway in esophagus cancer cells. While, IWP‐4 treatment inhibited the autophagy and limited esophagus cancer cells proliferation, migration, and invasion. Moreover, EPHB2 knocked down strengthened the effect of IWP‐4 treatment in regulating esophagus cancer cells proliferation, migration, and invasion. Finally, we illustrated that EPHB2 regulated the biological properties of esophagus cancer cells by modulating autophagy and Wnt/β‐catenin signaling pathway. Our study illustrated that EPHB2 might be a worthwhile target considering for the treatment of esophagus cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Digestive System, The First Affiliated Hospital of Jinzhou Medical University, 2 Section 5, Renmin Street, Guta District, Jinzhou City, Liaoning Province, China.
- Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, 2 Section 5, Renmin Street, Guta District, Jinzhou City, Liaoning Province, China.
Zitieren
APA
Cai, S., Ye, L., Zhong, Q., & Zhang, X. (2024). Silencing EPHB2 diminished the malignant biological properties of esophagus cancer cells by blocking autophagy and Wnt/β‐catenin pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23853
Vancouver
Cai S, Ye L, Zhong Q, Zhang X. Silencing EPHB2 diminished the malignant biological properties of esophagus cancer cells by blocking autophagy and Wnt/β‐catenin pathway. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23853
BibTeX
@article{Cai2024,
author = {Cai, Shusheng and Ye, Lianhua and Zhong, Qiming and Zhang, Xin},
title = {Silencing EPHB2 diminished the malignant biological properties of esophagus cancer cells by blocking autophagy and Wnt/β‐catenin pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23853}
}
EUVIMED